Chemoinformaics analysis of 4-AMINO-4-CARBOXYCHROMAN-2-ONE
Molecular Weight | 207.185 | nRot | 1 |
Heavy Atom Molecular Weight | 198.113 | nRig | 13 |
Exact Molecular Weight | 207.053 | nRing | 2 |
Solubility: LogS | -1.093 | nHRing | 1 |
Solubility: LogP | -0.801 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 27.0091 |
nHD | 2 | BPOL | 11.9309 |
QED | 0.508 |
Synth | 3.21 |
Natural Product Likeliness | 0.89 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.045 |
HIA | 0.007 |
CACO-2 | -5.699 |
MDCK | 0.00103417 |
BBB | 0.413 |
PPB | 0.157895 |
VDSS | 0.242 |
FU | 0.805976 |
CYP1A2-inh | 0.027 |
CYP1A2-sub | 0.096 |
CYP2c19-inh | 0.02 |
CYP2c19-sub | 0.126 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.28 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.188 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.212 |
CL | 2.391 |
T12 | 0.835 |
hERG | 0.003 |
Ames | 0.046 |
ROA | 0.367 |
SkinSen | 0.135 |
Carcinogencity | 0.136 |
EI | 0.103 |
Respiratory | 0.092 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.91611 |